Linkage to Care - Part I

This study has been completed.

Sponsor:

Collaborators:

National Institute on Drug Abuse (NIDA)

National Institute of Mental Health (NIMH)

Information provided by (Responsible Party):

University of North Carolina, Chapel Hill

ClinicalTrials.gov Identifier:

NCT00703040

First received: June 20, 2008

Last updated: February 27, 2017

Last verified: February 2016

History of Changes

Purpose

This first phase of a two-phase study involves three components:

Review of existing linkage-to-care protocols and sources of referrals for care;
Semi-structured telephone or face-to-face interviews with a minimum of two personnel per site who are associated with linkage to medical care. (Preference will be given to personnel with direct experience in linkage to care); and
Structured observations of referral sessions.

Condition
HIV


Study Type:	Observational
Study Design:	Observational Model: Other Time Perspective: Prospective
Official Title:	HIV-Related Care Engagement: Linkage to Care and Care-Seeking for HIV-Infected Adolescents, Phase I

Resource links provided by NLM:

MedlinePlus related topics: HIV/AIDS

U.S. FDA Resources

Further study details as provided by University of North Carolina, Chapel Hill:

Primary Outcome Measures:

Describe and evaluate community screening standards and practices. [ Time Frame: 1 year ]
Describe and evaluate the relationships of screening venues with care-providing venues. [ Time Frame: 1 year ]
Describe and evaluate referral and intake protocols. [ Time Frame: 1 year ]
Describe and evaluate care adherence support (including support from both clinical and non-clinical sources). [ Time Frame: 1 year ]


Enrollment:	35
Study Start Date:	March 2008
Study Completion Date:	March 2010
Primary Completion Date:	March 2010 (Final data collection date for primary outcome measure)

Groups/Cohorts
Component 1 Existing linkage to care protocols will be obtained from the 15 sites. This component does not involve study subjects.
Component 2 Person-to-person or telephone interviews with ATN clinical site staff and staff from their community partners will be audio-taped.
Component 3 Notes from direct observation of the linkage to medical care process within sites will be taken.

Eligibility


Ages Eligible for Study:	Child, Adult, Senior
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	Yes
Sampling Method:	Non-Probability Sample

Study Population

Component 1: The object of study is a collection of documents on existing linkage-to-care protocols and does not constitute a population. Component 2: Ideally, a minimum of two clinical staff and/or case managers from each of 15 AMTU and a minimum of one staff member representing the AMTU's community partners/sites where linkage to care activities occur. Component 3- Structured Observations: Clinical site staff providing linkage to care counseling. Please note that patients are not part of this study population. See Section 5.3 and Section 10.0 for additional details.

Criteria

Inclusion Criteria:

Component 1: Documents identified by clinical site personnel as pertaining to post-test counseling, linkage to care, or standard operating procedures addressing post-test counseling and linkage to care.
Component 2: Persons employed by one of the AMTUs or an identified linkage-to-care partner and work as clinical staff or a case-manager or is a person familiar to linkage to care; or persons involved in posttest counseling and linkage-to-care processes. Clinical staff and case managers are chosen based on direct experience in the assistance of HIV seropositive youth obtaining medical care. This definition includes, but is not limited to, physicians, nurses, psychologists, social workers, and case managers (who may have diverse professional backgrounds).
Component 3: All AMTU sites will be included.

Exclusion Criteria:

Component 1: No a priori exclusions.
Component 2: No a priori exclusions.
Component 3: No a priori exclusions.

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00703040

Locations


United States, District of Columbia
Children's National Medical Center
Washington, District of Columbia, United States, 20010-2970
United States, Florida
Childrens Diagnostic&Treatment Center
Fort Lauderdale, Florida, United States, 33316
University of Miami School of Medicine
Miami, Florida, United States, 33101
United States, New York
Montefiore Medical Center
Bronx, New York, United States, 10467
Mount Sinai Medical Center
Manhattan, New York, United States, 10128
United States, Pennsylvania
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States, 19104
United States, Tennessee
St. Jude Childrens Research Hospital
Memphis, Tennessee, United States, 38105

Sponsors and Collaborators

University of North Carolina, Chapel Hill

National Institute on Drug Abuse (NIDA)

National Institute of Mental Health (NIMH)

Investigators


Study Chair:	J. Dennis Fortenberry, MD	Adolescent Trials Network

More Information

Additional Information:

Adolescent Trials Network website This link exits the ClinicalTrials.gov site


Responsible Party:	University of North Carolina, Chapel Hill
ClinicalTrials.gov Identifier:	NCT00703040 History of Changes
Other Study ID Numbers:	ATN 066a
Study First Received:	June 20, 2008
Last Updated:	February 27, 2017

Keywords provided by University of North Carolina, Chapel Hill:


Care engagement Linkage to care HIV Infections

ClinicalTrials.gov processed this record on July 21, 2017

To Top